CyclophosphamideFISHBrachytherapyAdenocarcinomaBI-RADSCachexiaDocetaxelACChemotherapyBreastTomosynthesisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerImmunotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilLCISBOCAGuaranteedRenewableInsuranceGailModelGeneMutationAromataseInhibitorsFlowCytometryMRICystBreastCancerCheckpointInhibitorSelf-examinationNeoadjuvantTherapyTriple +/-BreastCancerKappaEpsilonGeneticCounselingPalpationRaloxifeneGermlineMutationBilateralProphylacticMastectomyPhyllodesTumorChemopreventionAngiogenesisCAMBRCAGeneCalcificationsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.HerceptinBevacizumabEGFRStagingAntibodyTherapyLumpectomyDimplingAbsoluteRiskWomen ages40+ shouldhave a clinicalbreast examat least yearlyTumorGradeAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPagetDisease1 in 8womenAnastrozolePaclitaxelLapatinibAntiemeticsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CytotoxicPARPInhibitorsRadiotherapyRADMultifocalTumorsLumpAyurvedaECOGScoreOvarianSuppressionPI3KinaseInhibitorsPathologicResponsePalbociclibAdvocacyChemotherapymTORInhibitorsIn-situCarcinomaMetastasisIntraductalPapillomaCapecitabineGeneticPredispositionLymphoscintigraphyDefinitiveSurgeryAlopeciaMultimodalityTherapyRelapseFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CMFChemotherapyKi-67RateEstrogen/EstradiolOligometastasesHormoneReceptorStatusDown-StagingHormoneReplacementTherapyBiopsyCo-survivorApoptosisCDK4/6InhibitorsHER-2Physicalactivity mayreduce therisk of breastcancersFibroadenomaTyrosine-KinaseInhibitorMethotrexateSERMMegestrolAcetateER+/-CytostaticEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMastodyniaProgestinDoseDenseTherapyAdjuvantTherapyMastectomyLymphNodeStatusDoxorubicinFamilyHistoryPrecisionMedicineTamoxifenMorpheaCyclophosphamideFISHBrachytherapyAdenocarcinomaBI-RADSCachexiaDocetaxelACChemotherapyBreastTomosynthesisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerImmunotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilLCISBOCAGuaranteedRenewableInsuranceGailModelGeneMutationAromataseInhibitorsFlowCytometryMRICystBreastCancerCheckpointInhibitorSelf-examinationNeoadjuvantTherapyTriple +/-BreastCancerKappaEpsilonGeneticCounselingPalpationRaloxifeneGermlineMutationBilateralProphylacticMastectomyPhyllodesTumorChemopreventionAngiogenesisCAMBRCAGeneCalcificationsWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.HerceptinBevacizumabEGFRStagingAntibodyTherapyLumpectomyDimplingAbsoluteRiskWomen ages40+ shouldhave a clinicalbreast examat least yearlyTumorGradeAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenPagetDisease1 in 8womenAnastrozolePaclitaxelLapatinibAntiemeticsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55CytotoxicPARPInhibitorsRadiotherapyRADMultifocalTumorsLumpAyurvedaECOGScoreOvarianSuppressionPI3KinaseInhibitorsPathologicResponsePalbociclibAdvocacyChemotherapymTORInhibitorsIn-situCarcinomaMetastasisIntraductalPapillomaCapecitabineGeneticPredispositionLymphoscintigraphyDefinitiveSurgeryAlopeciaMultimodalityTherapyRelapseFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CMFChemotherapyKi-67RateEstrogen/EstradiolOligometastasesHormoneReceptorStatusDown-StagingHormoneReplacementTherapyBiopsyCo-survivorApoptosisCDK4/6InhibitorsHER-2Physicalactivity mayreduce therisk of breastcancersFibroadenomaTyrosine-KinaseInhibitorMethotrexateSERMMegestrolAcetateER+/-CytostaticEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMastodyniaProgestinDoseDenseTherapyAdjuvantTherapyMastectomyLymphNodeStatusDoxorubicinFamilyHistoryPrecisionMedicineTamoxifenMorphea

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Cyclophosphamide
  2. FISH
  3. Brachytherapy
  4. Adenocarcinoma
  5. BI-RADS
  6. Cachexia
  7. Docetaxel
  8. AC Chemotherapy
  9. Breast Tomosynthesis
  10. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  11. Immunotherapy
  12. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  13. 5-Fluorouracil
  14. LCIS
  15. BOCA
  16. Guaranteed Renewable Insurance
  17. Gail Model
  18. Gene Mutation
  19. Aromatase Inhibitors
  20. Flow Cytometry
  21. MRI
  22. Cyst
  23. Breast Cancer
  24. Checkpoint Inhibitor
  25. Self-examination
  26. Neoadjuvant Therapy
  27. Triple +/- Breast Cancer
  28. Kappa Epsilon
  29. Genetic Counseling
  30. Palpation
  31. Raloxifene
  32. Germline Mutation
  33. Bilateral Prophylactic Mastectomy
  34. Phyllodes Tumor
  35. Chemoprevention
  36. Angiogenesis
  37. CAM
  38. BRCA Gene
  39. Calcifications
  40. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  41. Herceptin
  42. Bevacizumab
  43. EGFR
  44. Staging
  45. Antibody Therapy
  46. Lumpectomy
  47. Dimpling
  48. Absolute Risk
  49. Women ages 40+ should have a clinical breast exam at least yearly
  50. Tumor Grade
  51. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  52. Paget Disease
  53. 1 in 8 women
  54. Anastrozole
  55. Paclitaxel
  56. Lapatinib
  57. Antiemetics
  58. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  59. Cytotoxic
  60. PARP Inhibitors
  61. Radiotherapy
  62. RAD
  63. Multifocal Tumors
  64. Lump
  65. Ayurveda
  66. ECOG Score
  67. Ovarian Suppression
  68. PI3 Kinase Inhibitors
  69. Pathologic Response
  70. Palbociclib
  71. Advocacy
  72. Chemotherapy
  73. mTOR Inhibitors
  74. In-situ Carcinoma
  75. Metastasis
  76. Intraductal Papilloma
  77. Capecitabine
  78. Genetic Predisposition
  79. Lymphoscintigraphy
  80. Definitive Surgery
  81. Alopecia
  82. Multimodality Therapy
  83. Relapse
  84. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  85. CMF Chemotherapy
  86. Ki-67 Rate
  87. Estrogen/Estradiol
  88. Oligometastases
  89. Hormone Receptor Status
  90. Down-Staging
  91. Hormone Replacement Therapy
  92. Biopsy
  93. Co-survivor
  94. Apoptosis
  95. CDK4/6 Inhibitors
  96. HER-2
  97. Physical activity may reduce the risk of breast cancers
  98. Fibroadenoma
  99. Tyrosine-Kinase Inhibitor
  100. Methotrexate
  101. SERM
  102. Megestrol Acetate
  103. ER +/-
  104. Cytostatic
  105. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  106. Mastodynia
  107. Progestin
  108. Dose Dense Therapy
  109. Adjuvant Therapy
  110. Mastectomy
  111. Lymph Node Status
  112. Doxorubicin
  113. Family History
  114. Precision Medicine
  115. Tamoxifen
  116. Morphea